Princy Kumar, MD

Princy Kumar, MD, serves as chief of infectious diseases at MedStar Georgetown University Hospital and professor of medicine and microbiology at Georgetown University. She also leads clinical trials at Georgetown University Medical Center.

Articles by Princy Kumar, MD

DOR/ISL Maintains Viral Suppression in Phase 3 HIV Trials: Princy Kumar, MD

ByGiuliana Grossi,Princy Kumar, MD

April 28th 2026

Newly FDA-approved doravirine/Islatravir maintained HIV suppression in phase 3 trials with comparable safety and minimal metabolic effects.

Princy Kumar, MD

Articles by Princy Kumar, MD

DOR/ISL Maintains Viral Suppression in Phase 3 HIV Trials: Princy Kumar, MD

Latest Updated Articles

Trending on AJMC

FDA Approves First Oral Carbapenem Antibiotic for Complicated UTIs

EHA 2026 Had Something for Everyone, From Pediatric Practitioners to “Myeloma Maniacs”

Fourteen Years of HIV PrEP: How New Innovations Build on Decades of Progress in HIV

How MCOs Should Be Preparing for the OBBBA's Medicaid Cuts: David Brueggeman, MBA

Monoclonal Antibodies Had Varying Efficacy in Treating MG